The goal of this study was to evaluate the efficacy of cognitive-behavioral therapy for comorbid panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) by combining treatment strategies for both disorders. A single-case, multiple-baseline design across participants was used. Three participants with primary PDA and secondary GAD took part in the study. The efficacy of the treatment was assessed by means of a structured interview, self-administered questionnaires, and daily self-monitoring measures. After treatment, 2 of the 3 participants achieved high end-state functioning and maintained this level of functioning at 3-, 6-, and 12-month follow-ups. The third participant also improved but only reached high end-state functioning at 6-month follow-up. It therefore appears that the combined treatment is relatively effective for PDA–GAD comorbidity. Possible avenues for improving the treatment are suggested.
American Psychiatric Association. (1987). Diagnostical and statistical manual of mental disorders (3rd ed.). Washington, DC: Author .
2.
American Psychiatric Association. (1994). Diagnostical and statistical manual of mental disorders (4th ed.). Washington, DC: Author .
3.
Baldwin, D.S. (1998). Depression and panic: Comorbidity. European Psychiatry, 13(Suppl. 2), S65-S70.
4.
Barlow, D.H., & Hersen, M. (1984). Single case experimental designs: Strategies for studying behavior change (2nd ed.). New York: Pergamon.
5.
Beck, A.T., Rush, A.J., Shaw, B.F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford.
6.
Boivin, I., & Marchand, A. (1996). Evaluation structurée pour les troubles anxieux pour le DSM-IV [Anxiety disorder interview schedule for DSM-IV]. Montréal: Université du Québec à Montréal, Département de psychologie.
7.
Borkovec, T.D., Abel, J.L., & Newman, H. (1995). Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 63, 479-483.
8.
Bourque, P., & Beaudette, D. (1982). Etude psychométrique du Questionnaire de dépression de Beck auprès d'un échantillon d'étudiants universitaires francophones [Psychometric study of the Beck Depression Inventory in a French university student sample] . Canadian Journal of Behavioral Science/Revue Canadienne Des Sciences du Comportement, 14, 211-218.
Brawman-Mintzer, O., Lydiard, B.R., Emmanuel, N., Payeur, R., Johnson, M., Roberts, M.P., et al. (1993). Psychitric comorbidity in patients with generalized anxiety disorder. American Journal of Psychiatry,150, 1216-1218.
11.
Brown, C., & Schulberg, H.C. (1997). Depression and anxiety disorders: Diagnosis and treatment in primary care practice. In S. J. Gallant, G. P. Keita , & R. Royak-Schaler (Eds.), Health care for women: Psychological, social, and behavioral influences (pp. 237-256). Washington: American Psychological Association.
12.
Brown, T.A., Antony, M.M., & Barlow, D.H. (1995). Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbidity diagnoses following treatment . Journal of Consulting and Clinical Psychology, 63, 408-418.
13.
Buhr, K., & Dugas, M.J. (2002). The Intolerance of Uncertainty Scale: Psychometric properties of the English version. Behaviour Research and Therapy, 40, 931-946.
14.
Chambless, D.L., Caputo, G.C., Bright, P., & Gallagher, R. (1984). Assessment of fear of fear in agoraphobics: The Body sensation questionnaire and the Agoraphobic Cognitions Questionnaire . Journal of Consulting and Clinical Psychology, 52, 1090-1097.
15.
Chambless, D.L., Caputo, G.C., Jasin, S.E., Gracely, E.J., & Williams, C. (1985). The Mobility Inventory for Agoraphobia. Behavior Research and Therapy, 23, 35-44.
16.
Craske, M.G., & Barlow, D.H. (1993). Panic disorder and agoraphobia. In D. H. Barlow (Ed.), Clinical handbook of psychological disorders: A step-by-step treatment manual (2nd ed., pp. 1-47). New York: Guilford.
17.
Curry, J.F., & Murphy, L.B. (1995). Comorbidity of anxiety disorders. In J. S. March (Ed.), Anxiety disorders in children and adolescents (pp. 301-317). New York: Guilford .
18.
Di Nardo, P.A., Brown, T.A., & Barlow, D.H. (1994). Anxiety Disorders Interview Schedule for DSM-IV . Albany, New York: University of Albany.
19.
Dugas, M.J., Freeston, M.H., & Ladouceur, R. (1997). Intolerance of uncertainty and problem orientation in worry. Cognitive Therapy and Research, 21, 593-606.
20.
Dugas, M.J., Gosselin, P., & Ladouceur, R. (2001). Intolerance of uncertainty and worry: Investigating narrow specificity in a nonclinical sample. Cognitive Therapy and Research, 25, 551-558.
21.
Dugas, M.J., & Ladouceur, R. (2000). Treatment of GAD: Targeting intolerance of uncertainty in two types of worry. Behavior Modification, 24, 635-657.
22.
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., & Benjamin, L. (1990). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)New York: New York State Psychiatric Institute, Biometrics Research Department.
23.
Freeston, M.H., Rhéaume, J., Letarte, H., Dugas, M.J., & Ladouceur, R. (1994). Why do people worry? Personality and Individual Differences, 17, 791-802.
24.
Fyer, A.J., Liebowitz, M.R., & Klein, D.F. (1990). Treatment trials, comorbidity, and syndromal complexity . In J. D. Maser & C. R. Cloninger (Eds.), Comorbidity of mood and anxiety disorders (pp. 669-681). Washington, DC: American Psychiatric Press.
25.
Gauthier, J.G., & Bouchard, S. (1993). Adaptation canadienne-française de la forme révisée de State-Trait Anxiety Inventory de Spielberger A French Canadian adaptation of Spielberger's State-Trait Anxiety Inventory, revised version. Revue Canadienne des Sciences du Comportement, 25, 559-578.
26.
Goisman, R.M., Goldenberg, I., Vasile, R.G., & Keller, M.B. (1995). Comorbidity of anxiety disorders in a multicenter anxiety study. Comprehensive Psychiatry, 36, 303-311.
27.
Goldenberg, I.M., White, K., Yonkers, K., Reich, J., Warshaw, M.G., Goisman, R.M., et al. (1996). The infrequency of “pure culture” diagnosis among the anxiety disorders. Journal ofClinical Psychiatry, 57, 528-533.
28.
Gosselin, P., Dugas, M.J., Ladouceur, R., & Freeston, M.H. (2001). Evaluation des inquiétudes: Validation d'une traduction française du Penn State Worry Questionnaire Worries assessment: Validation of a French translation of the Penn State Worry Questionnaire . L'Encéphale, 25, 475-484.
29.
Jacobson, N.S., & Truax, P. (1992). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. In A. E. Kazdin (Ed.), Methodological issues and strategies in clinical research (pp. 631-648). Washington, DC: American Psychological Association.
30.
Keller, M.B., Yonkers, K.A., Warshaw, M.G., Pratt, L.A., Gollan, J.K., Massion, A.O., et al. (1994). Remission and relapse in subjects with panic disorder and panic with agoraphobia: A prospective short-interval naturalistic follow-up. Journal of Nervous and Mental Disease, 182, 290-296.
31.
Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry,51, 8-19.
32.
Labrecque, J., Dugas, M.J., Marchand, A., & Letarte, A. (2006). Cognitive-behavioral therapy for comorbid generalized anxiety disorder and panic disorder with agoraphobia. Behavior Modification, 30, 383-410.
33.
Labrecque, J., Leblanc, G., Kirouac, C., Stephenson, R., & Marchand, A. (2001, October). Validation d'un questionnaire mesurant la qualité de vie auprès d'un échantillon d'étudiants Validation of a questionnaire measuring quality of life in student sample. Poster presented at the 24th congrès de la Société Québécoise de Recherche en Psychologie , Chicoutimi, Québec, Canada.
34.
Ladouceur, R., & Bégin, G. (1980). Protocoles de recherche en sciences appliquées et fondamentales [Research protocols in applied and fundamental sciences] . St-Hyacinthe, Canada: Edisem.
35.
Ladouceur, R., Dugas, M.J., Freeston, M.H., Léger, E., Gagnon, F., & Thibodeau, N. (2000). Efficacy of a new cognitive-behavioral treatment for generalized anxiety disorder: Evaluation in a controlled clinical trial . Journal of Consulting and Clinical Psychology, 68, 957-964.
36.
Ladouceur, R., Freeston, M.H., Dumont, J., Letarte, H., Rhéaume, J., Gagnon, F., et al. (1992). Penn State Worry Questionnaire: Validity and reliability of a French translation. Canadian Psychology , 33, 236.
37.
Lapalme, M., & Hodgins, S. (1998). Entrevue clinique structurée pour le DSM-IV Axe II: Troubles de la personnalité [Structured clinical interview for DSM-IV Axis II: Personality disorders]. Montréal, Québec, Canada: Université de Montréal, Département de psychologie, Groupe de Recherche sur le Développement des Troubles Affectifs.
38.
Marshall, J.R. (1996). Comorbidity and its effects on panic disorder . Bulletin of the Menninger Clinic, 60, 39-53.
39.
McNally, R.J., & Lorenz, M. (1987). Anxiety sensitivity in agoraphobics. Journal of Behavior Therapy and Experimental Psychiatry, 18, 3-11.
40.
Meyer, T.J., Miller, M.L., Metzger, R.L., & Borkovec, T.D. (1990). Development and validation of the Penn State Worry Questionnaire. Behavior Research and Therapy, 28, 487-495.
41.
Noyes, R., Jr. (2001). Comorbidity in generalized anxiety disorder. The Psychiatric Clinics of North America, 24, 41-55.
42.
Noyes, R., Jr., Woodman, C., Garvey, M.J., Cook, B.L., Suelzer, M., Clancy, J., & et al. (1992). Generalized anxiety disorder vs panic disorder. The Journal of Nervous and Mental Disease, 180, 369-379.
43.
Provencher, M.D., Ladouceur, R., & Dugas, M.J. (2006). La comorbidité dans le trouble d'anxiété généralisée: Prévalence et évolution suite à une thérapie cognitivocomportementale [Comorbidity in generalized anxiety disorder: Prevalence and evolution following a cognitive-behavioral therapy]. Revue Canadienne de Psychiatrie/Canadian Journal of Psychiatry, 51, 91-99.
44.
Reiss, S., Peterson, R.A., Gursky, D.M., & McNally, R.J. (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behavior Research and Therapy, 24, 1-8.
45.
Roy-Byrne, P.P., & Katon, W. (1999). Generalized anxiety disorder in primary care: The precursor/modifier pathway to increased health care utilisation. Journal of clinical psychiatry, 58(Suppl. 3), 34-40.
46.
Sanderson, W.C., Di Nardo, P.A., Rapee, R.M., & Barlow, D.H. (1990). Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology , 99, 308-312.
47.
Sanderson, W.C., & Wetzler, S. (1991). Chronic anxiety and generalized anxiety disorder: Issues in comorbidity. In R. M. Rapee & D. H. Barlow (Eds.), Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression (pp. 119-135). New York: Guilford.
48.
Schweizer, E., & Rickels, K. (1996). The long term management of GAD: Issues and dilemmas . Journal of Clinical Psychiatry, 57(Suppl7.9-12.
49.
Souêtre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J.M., Adès, J., et al. (1994). Cost of anxiety disorders: Impact of comorbidity . Journal of Psychosomatic Research, 38(Suppl. 1), 151-160.
50.
Spielberger, C.D. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press.
51.
Starcevic, V., Uhlenhuth, E.H., Kellner, R., & Patack, D. (1992). Patterns of comorbidity in panic disorder and agoraphobia. Psychiatry Research, 42, 171-183.
52.
Steketee, G., Chambless, D.L., & Tran, G.Q. (2001). Effects of axis I and axis II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry, 42, 76-86.
53.
Stephenson, R., Marchand, A., & Lavallée, M.C. (1997). Validation de l'Inventaire de mobilité pour l'agoraphobie auprès de la population québécoise francophone [Validation of Mobility Inventory for Agoraphobia in a French population of Québec]. Science et Comportement, 26, 1-22.
54.
Stephenson, R., Marchand, A., & Lavallée, M.C. (1998). Validation du Questionnaire des sensations physiques auprès de la population canadienne-française [Validation of Body Sensation Questionnaire in a French-Canadian population]. L'Encéphale, 24, 415-425.
55.
Stephenson, R., Marchand, A., & Lavallée, M.C. (1999). French-Canadian adaptation of the Agoraphobic Cognitions Questionnaire: Cross-cultural validation and gender differences. Scandinavian Journal ofBehavior Therapy , 28, 58-69.
56.
Swinson, R.P., Cox, B.J., Kerr, S.A., Kuch, K., & Fergus, K.D. (1992). A survey of anxiety disorders clinics in Canadian hospitals. Canadian Journal of Psychiatry, 37, 188-191.
57.
Tsao, J.C.I., Lewin, M.R., & Craske, M.G. (1998). The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. Journal of Anxiety Disorders, 12, 357-371.
58.
Tsao, J.C., Mystkovski, J.L., Zucker, B.G., & Craske, M.G. (2002). Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: Replication and extension. Behavior Therapy, 33, 493-509.
59.
Tsao, J.C., Mystkovski, J.L., Zucker, B.G., & Craske, M.G. (2005). Impact of cognitive-behavioral therapy for panic disorder on comorbidity: A controlled investigation. Behaviour Research and Therapy, 43, 959-970.
60.
Verreault, N., Labrecque, J., Marchand, A., & Marchand, L. (in press). Validation de l'Index de sensibilité à l'anxiété auprès de la population québécoise francophone [Validation of the Anxiety Sensitivity Index in a French population of Québec]. Revue Québécoise de Psychologie.
